Big news comes in a very small package for the more than 200,000 Americans who get a pacemaker each year to treat slow or irregular heart rhythms. Last week, the U.S. Food and Drug Administration ...
This story is part of a series on the current progression in Regenerative Medicine. This piece discusses the regeneration of the cardiovascular system. In 1999, I defined regenerative medicine as the ...
Newport Beach, Calif.-based Hoag Memorial Hospital Presbyterian has implanted one of the world’s first dual-chamber leadless pacemaker in a patient, a minimally invasive procedure recently cleared by ...
Just a few weeks after Abbott presented the successful results of a trial of its Aveir DR dual-chamber leadless pacemaker system—data that it said had been promptly submitted for regulatory review—the ...
Please provide your email address to receive an email when new articles are posted on . A dual-chamber leadless pacemaker met 3-month safety and efficacy performance goals. The device avoids ...
CINCINNATI (WKRC) - One of the first patients to receive some high-tech heart help is saying thank you to the team at St. Elizabeth Health after they helped give him back part of his life. One of the ...
The FDA approved the Aveir DR dual-chamber leadless pacemaker, the first such device to make it to the market, manufacturer Abbott announced. Approved for the treatment of abnormal or slow heart ...
Single-chamber ventricular leadless pacemakers do not support atrial pacing or consistent atrioventricular synchrony. A dual-chamber leadless pacemaker system consisting of two devices implanted ...
NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- A revolutionary advancement in cardiac care is changing what’s possible for people living with slow or abnormal heart rhythms. On October 13th, Abbott ...
(RTTNews) - Abbott Laboratories (ABT) a biopharmaceutical major, announced on Wednesday that it has received FDA approval for its dual chamber (DR) leadless pacemaker system dubbed AVEIR. As per the ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window NEW ORLEANS -- A ...
The FDA has approved Abbott Laboratories' ABT AVEIR dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacing system to treat abnormal or slow heart rhythms. Through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results